ABX advanced biochemical compounds - biomedizinische forschungsreagenzien gmbh:1234166 [18-008610]
Ended Purchase Order Awarded Last action
- Contract number
- 75N90018P00441
- Awardee
-
ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH UEI LAHNMPWWFFJ9
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,669
Award facts
- Contract value 100% obligated
- $11,668.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The NIH Clinical Center awarded a purchase order to ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH for $11,668.80 on May 8, 2018. The order is firm fixed price with no set-aside designation. Place of performance is Bethesda, Maryland. The ultimate completion date is June 7, 2018. The source does not describe the specific biochemical compounds or research reagents procured.
Quick answers
Who was awarded contract 75N90018P00441?
75N90018P00441 was awarded to ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH by NIH Clinical Center (National Institutes of Health) on May 8, 2018.
How much is contract 75N90018P00441 worth?
The government has obligated $11,669 on 75N90018P00441.
Was contract 75N90018P00441 competed?
The extent of competition for 75N90018P00441 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award